Fmoc-L-His(Mtt)-OH

Fmoc-L-His(Mtt)-OH is an Fmoc-protected L-histidine derivative bearing an Mtt (methyltrityl) protecting group on the imidazole N of the side chain. The molecule combines a stereochemically defined amino acid backbone with a base-sensitive heteroaromatic ring protected to modulate nucleophilicity and minimize side reactions during peptide coupling. The Fmoc group enables standard base-labile N-deprotection, while the Mtt group provides orthogonal protection that can be removed under conditions compatible with many peptide synthesis workflows. The resulting functional profile supports controlled imidazole chemistry for downstream derivatization, including conversion to substituted histidine motifs and preparation of peptide building blocks with defined side-chain reactivity.

1. Peptide Synthesis

Fmoc-L-His(Mtt)-OH supports solid-phase peptide synthesis and solution-phase peptide coupling where histidine side-chain reactivity must be suppressed during amide bond formation. The Fmoc-protected alpha-amino group participates in iterative coupling cycles, while the Mtt-protected imidazole nitrogen reduces undesired coordination, oxidation, or side-chain participation under coupling and deprotection conditions. Orthogonality between Fmoc removal and Mtt stability enables selective exposure of the histidine functionality at a chosen stage, supporting controlled incorporation of histidine residues into peptides. Downstream, the unmasked imidazole can be used to construct metal-binding peptides, recognition motifs, and enzymatically relevant sequences used in biochemical research and peptide science.

2. Side-Chain Functionalization

Fmoc-L-His(Mtt)-OH serves as a protected amino acid intermediate for side-chain functionalization strategies that require controlled access to the imidazole. The Mtt group temporarily masks the histidine imidazole nitrogen, enabling derivatization planning without premature reactions during synthesis or purification. Selective deprotection can reveal the imidazole for subsequent transformations such as alkylation, acylation, or incorporation into conjugation-ready peptide analogs, including histidine-tagged constructs for affinity workflows. The defined stereochemistry of the L-histidine backbone helps maintain consistent structure-function relationships across synthetic libraries and downstream functional molecule generation.

3. Chemical Biology Labeling

Fmoc-L-His(Mtt)-OH can be applied in chemical biology workflows that require histidine-containing peptides with controlled imidazole availability for labeling and probe construction. The protected imidazole allows peptide assembly without uncontrolled binding to metal surfaces or reactive intermediates, while later unmasking enables site-specific reactivity compatible with conjugation chemistries. The Fmoc handle supports incorporation into longer peptide scaffolds used as biochemical research intermediates, including probes for studying protein-ligand interactions and metal-dependent binding environments. The resulting histidine-bearing products can be further processed into analytical standards or functional reagents for molecular recognition studies in applied research settings.

4. Peptidomimetics And SAR Studies

Fmoc-L-His(Mtt)-OH is suitable for peptidomimetic construction and SAR-focused synthesis where histidine side-chain geometry and reactivity must be controlled. The amino acid backbone provides a defined stereocenter for consistent spatial presentation, while the protected imidazole enables incorporation into analogs without perturbing coupling steps or causing heteroaromatic side reactions. Selective deprotection and subsequent modification of the imidazole can generate a set of histidine variants for structure-activity relationship studies, including metal-binding or hydrogen-bonding tuned analogs. The compound thus functions as a chiral intermediate for systematic scaffold diversification in medicinal chemistry and applied peptide-analog development.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-His(Mtt)-OH can be employed as a manufacturing-relevant protected amino acid building block for producing histidine-containing peptide intermediates used in fine chemical synthesis. The Fmoc strategy supports standardized N-protection handling, while the Mtt-protected imidazole reduces side-chain reactivity during repeated coupling and purification operations typical of peptide manufacturing routes. Orthogonal deprotection behavior supports staged processing, enabling controlled generation of reactive histidine residues for further downstream transformations or final assembly steps. The chiral, protected structure aligns with industrial requirements for reproducible peptide building block preparation, enabling consistent downstream conversion into peptide-based intermediates and functional products.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

5. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis